Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Home workouts may help endometrial cancer survivors shed pounds

NCT ID NCT02774759

Symptom relief Sponsor: M.D. Anderson Cancer Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Sep 18, 2026 · Updated 2 times

Summary

This study tests whether a home-based weight loss program, with or without resistance training, is practical for endometrial cancer survivors. Fifteen participants will follow a program using a workbook, fitness tracker, and coaching calls. The goal is to see if they can lose weight and keep muscle mass, with results measured at 6 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
home-based weight loss program with aerobic exercise and optional resistance training
What this could lead to
If successful, this could show that a simple home exercise program helps endometrial cancer survivors lose weight and maintain muscle mass, improving their quality of life.
What could go wrong
This is a very small feasibility study with only 15 participants, so results may not apply to everyone. It is not designed to prove long-term health benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

15 people

The number who actually took part.

Started

Oct 2016

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Diagnosed with Stage I-II endometrial cancer 2. Six to 36 months post treatment 3. Body mass index (BMI) 30-\<45 kg/m2 4. Age of at least 18 years 5. Access to a telephone for coaching sessions and access to a computer, smartphone, or tablet for syncing Fitbit devices 6. Can speak and read English 7. Can provide informed consent 8. Willing to travel to MD Anderson's main campus for 2 visits (baseline and 6 months post-baseline) Exclusion Criteria: 1. Unmanaged lymphedema 2. Medical contraindications to home-based exercise or low-fat, high fruit and vegetable diet 3. Functional limitations requiring a walker/scooter/wheelchair for daily activities 4. Recurrent disease 5. Vigorous exercise \> or = 60 min/week or moderate exercise \> or = 150 min/week. If a combination of moderate and vigorous exercise are preformed, the minutes of moderate exercise/week plus 2 x minutes of vigorous exercise/week \> or = 150 min/week. 6. Resistance training on \> or = 2 days/week accounting for more than 30 minutes of strength training per week 7. Enrollment in a structured weight loss program in the past 6 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Endometrial cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

endometrial cancer female reproductive organ cancer Obesity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Malignant neoplasms of female genital organs

Contacts and locations

Locations

  • University of Texas MD Anderson Cancer Center

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.